Development And Licence Agreement With Douglas Pharmaceuticals
Oct 17 (Reuters) - Zoono Group Ltd ZNO.AX :
* ENTERS INTO CO-DEVELOPMENT AND LICENCE AGREEMENT WITH
DOUGLAS
PHARMACEUTICALS
* IN DEAL PATIES AGREED TO GRANT LICENCE TO ITS 'BACKGROUND
IP' TO
ENABLE PARTIES TO JOINTLY DEVELOP SPECIALTY PRODUCTS FOR SALE
Source text for Eikon: ID:nASX75m2Vy
Further company coverage: ZNO.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Zoono
See all newsBrief: Zoono Group Undertakes Non-Renounceable Rights Issue
Australia's Zoono advances on order win from Groupe Guillin's UK arm
Brief: Zoono Group Says Material Commercial Orders For Product Into UK Soft Fruits Market
Brief: Zoono Group Announces Exclusive Australian Packaging Agreement With Multisteps
Brief: Zoono Group Requests Trading Halt Pending ASX Price Query Response